XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
117 hedge funds and large institutions have $785M invested in Acceleron Pharma in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less call options, than puts
Call options by funds: $3.25M | Put options by funds: $5.1M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
117
Holding in Top 10
3
Calls
$3.25M
Puts
$5.1M
Top Buyers
| 1 | +$7.69M | |
| 2 | +$4.11M | |
| 3 | +$3.97M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.67M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.16M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$16.1M | |
| 3 | -$13.8M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$13.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.87M |